Cancer epigenomics: DNA methylomes and histone-modification maps
By Manel Esteller. Nature reviews genetics, 2007
2,210 citations recorded by the source corpus.
Subfields: Molecular Biology
View Paper: https://www.semanticscholar.org/paper/8c4c3dfbbdfe636999a267f0a7e88a8d0e33d8e6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Manel Esteller
- Peter A. Jones
- S. Baylin
- Carlo Maria Croce
- Hao Wu
- Yi Zhang
- George A. Calin
- R. Weinberg
Citations in the corpus
- Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine (2008, background): “Hypermethylation-induced gene silencing of tumor suppressor and other cancer-related genes plays a fundamental role in human tumorigenesis.(15) The reversion of these epigenetic mutations can therefore restore proliferation control and apoptosis sensitivity.”
- Current and Future Development in Lung Cancer Diagnosis (2021, background): “DNA methylation and histone modification modulate gene expression that could influence early lung cancer detection [47].”
- Reversing DNA Methylation: Mechanisms, Genomics, and Biological Functions (2014, positive): “DNA Demethylation and Cancer Aberrant DNA methylation is one of the hallmarks associated with cancer cells (Baylin and Jones, 2011; Esteller, 2007).”
- Epigenetic Determinants of Cancer. (2016, background): “The most well-understood mechanism by which DNA methylation contributes to cancer is through association with the focal hypermethylation of promoters at TSGs.”
- Cancer Genetics and Epigenetics: Two Sides of the Same Coin? (2012, background): “Mutations or translocations of these genes are observed in colon, 14 Cancer Cell 22, July 10, 2012 ª2012 Elsevier Inc. uterine, and lung tumors and in leukemias (Esteller, 2007).”
- DNA methylation and cancer. (2010, background): “Thus, regulation of packaging of DNA ensures maintenance of correct chromosome replication, gene expression, and stable gene silencing (Esteller, 2007).”
- Hallmarks of cancer: the next generation. (2011, positive): “, inactivation of tumor suppressor genes, can also be acquired through epigenetic mechanisms such asDNAmethylation and histonemodifications (Berdasco and Esteller, 2010; Esteller, 2007; Jones and Baylin, 2007), some clonal expansions may well be triggered by nonmutational changes affecting the regul”
- SWAN: Subset-quantile Within Array Normalization for Illumina Infinium HumanMethylation450 BeadChips (2012, background): “Changes in DNA methylation are vital for normal development and differentiation [1], whilst aberrant methylation is involved in diseases such as diabetes, schizophrenia, multiple sclerosis and cancer [2-4].”
- Non-coding RNAs in disease: from mechanisms to therapeutics (2023, positive): “Generally, in diseased tissues, ncRNAs are dysregulated as a consequence of genomic structural and copy number variations, epigenetic modifications or transcription factor alterations 99,100 .”
- A microRNA DNA methylation signature for human cancer metastasis (2008, background): “In classical tumor suppressor genes, promoter CpG island hypermethylation occurs in genes involved in cell adherence, invasion, and angiogenesis, such as cadherins, tissue inhibitors of metalloproteinases, and thrombospondins (18).”